Stocktoria
Kyverna Therapeutics, Inc. KYTX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2024-02-08
Kyverna Therapeutics, Inc. statistics & valuation
Market cap$513.1M
P / B2.2×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Return on assets | -54.9% | -41.8% | -80.3% |
| Return on equity | -69.4% | -47.8% | 459.4% |
| Current ratio | 7.75 | 8.61 | 3.05 |
Source: SEC EDGAR filings · CIK 0001994702 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.